richeldi

Accused of sexual assault on a patient, pulmonologist Luca Richeldi asks for a plea deal

L'Unione Sarda.it - 07 May 2024
Accused of sexual assault on a patient, pulmonologist Luca Richeldi asks for a plea deal  ...

• More

Professor Luca Richeldi Indicted for Sexual Assault: Trial Set for June 3 - Il Messaggero

English edition - 02 Oct 2024
Professor Luca Richeldi Indicted for Sexual Assault: Trial Set for June 3  ...

• More

Lung Disease: In Clinical Trial New Boehringer Ingelheim Drug Prevented Worsening of IPF

MedicalResearch.com - 15 May 2024
Lung Disease: In Clinical Trial New Boehringer Ingelheim Drug Prevented Worsening of IPF  ...

• More

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

nejm.org - 15 May 2022
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis  ...

• More

Luca Richeldi: high hopes for rare lung diseases

The Lancet - 13 May 2017
Luca Richeldi: high hopes for rare lung diseases  ...

• More

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

nejm.org - 18 May 2014
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis  ...

• More

Idiopathic pulmonary fibrosis: moving forward

BMC Medicine - 24 Sep 2015
Idiopathic pulmonary fibrosis: moving forward  ...

• More

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone

Frontiers - 08 Feb 2024
Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone  ...

• More

Protective effect of Amomum Roxb. essential oils in lipopolysaccharide-induced acute lung injury mice and its metabolomics

ScienceDirect.com - 23 May 2022
Protective effect of Amomum Roxb. essential oils in lipopolysaccharide-induced acute lung injury mice and its metabolomics  ...

• More

Advancing Care for Idiopathic Pulmonary Fibrosis (IPF): Evaluating Current Treatments and Emerging Therapies for Improved Patient Outcomes

AJMC.com Managed Markets Network - 30 Sep 2024
Advancing Care for Idiopathic Pulmonary Fibrosis (IPF): Evaluating Current Treatments and Emerging Therapies for Improved Patient Outcomes  ...

• More

(PDF) Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis

ResearchGate - 22 Oct 2024
(PDF) Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis  ...

• More

Idiopathic pulmonary fibrosis

The Lancet - 05 May 2018
Idiopathic pulmonary fibrosis  ...

• More

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

nejm.org - 22 Sep 2011
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis  ...

• More

Idiopathic pulmonary fibrosis: diagnosis, management and new therapies

BioMed Central - 30 Jul 2017
Idiopathic pulmonary fibrosis: diagnosis, management and new therapies  ...

• More

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

nejm.org - 29 Sep 2019
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases  ...

• More

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis

nejm.org - 15 Sep 2018
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis  ...

• More

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

nejm.org - 03 Jun 2018
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis  ...

• More

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis

nejm.org - 16 Sep 2018
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis  ...

• More

PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis

nejm.org - 08 Jun 2022
PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis  ...

• More